Carescape ONE; Carescape Dock F0; TruSignal ECG MM; TruSignal PRES MM; TruSignal TEMP MM; TruSignal SpO2 MM 1.8M; TruSignal SpO2 MM 3.0M
GE Healthcare Finland Oy · Decision date Sep 1, 2026
What did the FDA decide?
FDA recorded a substantially equivalent decision for K260656 on September 1, 2026, with GE Healthcare Finland Oy as applicant. The submission covers Carescape ONE with Carescape Software version 4.0, Carescape Dock F0, and five TruSignal micro-modules: ECG, PRES, TEMP, and SpO2 in 1.8M and 3.0M cable lengths. The micro-modules connect through medical-grade USB ports, each dedicated to one vital sign. The primary regulation is 21 CFR 870.1025 under product code MHX, with additional product codes listed in the summary.
The summary describes Carescape ONE as a bedside monitor usable during intrahospital transport, operating standalone or as an accessory to a compatible host monitor. The dock supplies DC power, charges the battery, and provides host communication. The summary states the dock and micro-modules are not intended for use within a controlled MR environment. The record does not include the decision statement text, performance testing results, or a comparison to a predicate device, so the basis for the equivalence finding is not established here. Substantial equivalence is a clearance, not a PMA approval.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 1, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260656
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- GE Healthcare Finland Oy
- Product code
- MHX
- Decision code
- SESE
- Decision date
- Sep 1, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Monitor, Physiological, Patient(With Arrhythmia Detection Or Alarms).
- Applicant
- GE Healthcare Finland Oy
- Product code
- MHX
- FDA device class
- 2
FDA decision timeline
K260656 received
Application receipt date recorded by FDA.
K260656 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code MHX
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
12SL PrecisionK261307 | Ge Medical Systems Information Technologies, Inc. | 510(k) clearance | Nov 3, 2026 | FDA |
Radius VSM and AccessoriesK260676 | Masimo Corporation | 510(k) clearance | Oct 14, 2026 | FDA |
| GE Healthcare Finland Oy | 510(k) clearance | Aug 28, 2026 | FDA | |
| Draeger Medical Systems, Inc. | 510(k) clearance | Aug 20, 2026 | FDA | |
| Edan Instruments, Inc. | 510(k) clearance | Aug 6, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
GE Healthcare Finland Oy
- Headquarters
- Not reported
- Brand website
- gehealthcare.com
- FDA applicant address
- Helsinki
Sources and methodology
- Original FDA record: K260656
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



